Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 200

1.

Altered neuregulin 1-erbB4 signaling contributes to NMDA receptor hypofunction in schizophrenia.

Hahn CG, Wang HY, Cho DS, Talbot K, Gur RE, Berrettini WH, Bakshi K, Kamins J, Borgmann-Winter KE, Siegel SJ, Gallop RJ, Arnold SE.

Nat Med. 2006 Jul;12(7):824-8. Epub 2006 Jun 11.

PMID:
16767099
2.

Schizophrenia: more evidence for less glutamate.

Morrison PD, Pilowsky LS.

Expert Rev Neurother. 2007 Jan;7(1):29-31.

PMID:
17187494
3.

Perinatal phencyclidine treatment alters neuregulin 1/erbB4 expression and activation in later life.

du Bois TM, Newell KA, Huang XF.

Eur Neuropsychopharmacol. 2012 May;22(5):356-63. doi: 10.1016/j.euroneuro.2011.09.002. Epub 2011 Oct 1.

PMID:
21962913
4.

Neuregulin 1-erbB4 pathway in schizophrenia: From genes to an interactome.

Banerjee A, Macdonald ML, Borgmann-Winter KE, Hahn CG.

Brain Res Bull. 2010 Sep 30;83(3-4):132-9. doi: 10.1016/j.brainresbull.2010.04.011. Epub 2010 Apr 28. Review.

PMID:
20433909
5.

Reciprocal signalling between NR2 subunits of the NMDA receptor and neuregulin1 and their role in schizophrenia.

Geddes AE, Huang XF, Newell KA.

Prog Neuropsychopharmacol Biol Psychiatry. 2011 Jun 1;35(4):896-904. doi: 10.1016/j.pnpbp.2011.02.017. Epub 2011 Mar 1. Review.

PMID:
21371516
6.

Schizophrenia susceptibility pathway neuregulin 1-ErbB4 suppresses Src upregulation of NMDA receptors.

Pitcher GM, Kalia LV, Ng D, Goodfellow NM, Yee KT, Lambe EK, Salter MW.

Nat Med. 2011 Apr;17(4):470-8. doi: 10.1038/nm.2315. Epub 2011 Mar 27.

7.

Neuregulin1/ErbB4-induced migration in ST14A striatal progenitors: calcium-dependent mechanisms and modulation by NMDA receptor activation.

Pregno G, Zamburlin P, Gambarotta G, Farcito S, Licheri V, Fregnan F, Perroteau I, Lovisolo D, Bovolin P.

BMC Neurosci. 2011 Oct 12;12:103. doi: 10.1186/1471-2202-12-103.

8.

Neuregulin1 (NRG1) signaling through Fyn modulates NMDA receptor phosphorylation: differential synaptic function in NRG1+/- knock-outs compared with wild-type mice.

Bjarnadottir M, Misner DL, Haverfield-Gross S, Bruun S, Helgason VG, Stefansson H, Sigmundsson A, Firth DR, Nielsen B, Stefansdottir R, Novak TJ, Stefansson K, Gurney ME, Andresson T.

J Neurosci. 2007 Apr 25;27(17):4519-29.

9.

A neuregulin 1 transmembrane domain mutation causes imbalanced glutamatergic and dopaminergic receptor expression in mice.

Newell KA, Karl T, Huang XF.

Neuroscience. 2013 Sep 17;248:670-80. doi: 10.1016/j.neuroscience.2013.06.037. Epub 2013 Jun 27.

PMID:
23811072
10.

Antipsychotic treatment and neuregulin 1-ErbB4 signalling in schizophrenia.

Pan B, Huang XF, Deng C.

Prog Neuropsychopharmacol Biol Psychiatry. 2011 Jun 1;35(4):924-30. doi: 10.1016/j.pnpbp.2011.04.002. Epub 2011 Apr 13. Review.

PMID:
21513767
11.

Positive and negative symptoms in schizophrenia: the NMDA receptor hypofunction hypothesis, neuregulin/ErbB4 and synapse regression.

Bennett M.

Aust N Z J Psychiatry. 2009 Aug;43(8):711-21. doi: 10.1080/00048670903001943. Review.

PMID:
19629792
12.

Neuregulin-1 signalling and antipsychotic treatment: potential therapeutic targets in a schizophrenia candidate signalling pathway.

Deng C, Pan B, Engel M, Huang XF.

Psychopharmacology (Berl). 2013 Mar;226(2):201-15. doi: 10.1007/s00213-013-3003-2. Epub 2013 Feb 7. Review.

PMID:
23389757
13.

Expressions of neuregulin 1beta and ErbB4 in prefrontal cortex and hippocampus of a rat schizophrenia model induced by chronic MK-801 administration.

Feng Y, Wang XD, Guo CM, Yang Y, Li JT, Su YA, Si TM.

J Biomed Biotechnol. 2010;2010:859516. doi: 10.1155/2010/859516. Epub 2010 May 4.

14.

Alteration of BACE1-dependent NRG1/ErbB4 signaling and schizophrenia-like phenotypes in BACE1-null mice.

Savonenko AV, Melnikova T, Laird FM, Stewart KA, Price DL, Wong PC.

Proc Natl Acad Sci U S A. 2008 Apr 8;105(14):5585-90. doi: 10.1073/pnas.0710373105. Epub 2008 Apr 2.

15.

Biological validation of increased schizophrenia risk with NRG1, ERBB4, and AKT1 epistasis via functional neuroimaging in healthy controls.

Nicodemus KK, Law AJ, Radulescu E, Luna A, Kolachana B, Vakkalanka R, Rujescu D, Giegling I, Straub RE, McGee K, Gold B, Dean M, Muglia P, Callicott JH, Tan HY, Weinberger DR.

Arch Gen Psychiatry. 2010 Oct;67(10):991-1001. doi: 10.1001/archgenpsychiatry.2010.117.

16.

Regulation of NMDA receptors by neuregulin signaling in prefrontal cortex.

Gu Z, Jiang Q, Fu AK, Ip NY, Yan Z.

J Neurosci. 2005 May 18;25(20):4974-84.

17.

Neuregulin 1/ErbB4 enhances synchronized oscillations of prefrontal cortex neurons via inhibitory synapses.

Hou XJ, Ni KM, Yang JM, Li XM.

Neuroscience. 2014 Mar 7;261:107-17. doi: 10.1016/j.neuroscience.2013.12.040. Epub 2013 Dec 27.

PMID:
24374327
18.

The ERBB4 intracellular domain (4ICD) regulates NRG1-induced gene expression in hippocampal neurons.

Allison JG, Das PM, Ma J, Inglis FM, Jones FE.

Neurosci Res. 2011 Jun;70(2):155-63. doi: 10.1016/j.neures.2011.02.009. Epub 2011 Feb 23.

PMID:
21352860
19.

TrkB interacts with ErbB4 and regulates NRG1-induced NR2B phosphorylation in cortical neurons before synaptogenesis.

Pandya CD, Pillai A.

Cell Commun Signal. 2014 Jul 24;12:47. doi: 10.1186/s12964-014-0047-9.

20.

Neuregulin 1 and schizophrenia.

Stefansson H, Steinthorsdottir V, Thorgeirsson TE, Gulcher JR, Stefansson K.

Ann Med. 2004;36(1):62-71. Review.

PMID:
15000348
Items per page

Supplemental Content

Write to the Help Desk